AVDL NASDAQ
Avadel Pharmaceuticals plc
1W: +0.1%
1M: +0.6%
3M: +43.7%
1Y: +104.5%
3Y: +208.7%
5Y: +207.4%
$21.64
Last traded 2025-12-31 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
#30
of 304
Drug Manufacturers - Specialty & Generic
Technical Signal Map
1 Bullish
1 Neutral
3 Bearish
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| AVDL Avadel Pharmaceuticals plc | $2.1B | 216.0 | -0.3 | 8.1 | 0.0 | 79.9 | 5 | N/A | 104.5 |
| PRGO Perrigo Company plc | $1.9B | -1.1 | -49.6 | 3.1 | 7.3 | -4.2 | 4 | LEAN BULL | -35.2 |
| 0Y5E.L Perrigo Co. Plc | $2.0B | -1.1 | -49.7 | 3.3 | 7.3 | -4.2 | 4 | LEAN BEAR | -36.6 |
| MLC.IR Malin Corporation plc | $30M | 295.4 | -1.9 | -17.2 | — | — | 1 | BEARISH | -12.5 |
| ALKS Alkermes plc | $6.8B | 103.6 | 3.9 | 2.9 | 0.1 | 10.8 | 4 | BEARISH | 36.2 |
| AVDL Avadel Pharmaceuticals plc | $2.1B | 216.0 | -0.3 | 8.1 | 0.0 | 79.9 | 5 | N/A | 104.5 |
| PRGO Perrigo Company plc | $1.9B | -1.1 | -49.6 | 3.1 | 7.3 | -4.2 | 4 | LEAN BULL | -35.2 |
| 0Y5E.L Perrigo Co. Plc | $2.0B | -1.1 | -49.7 | 3.3 | 7.3 | -4.2 | 4 | LEAN BEAR | -36.6 |
| MLC.IR Malin Corporation plc | $30M | 295.4 | -1.9 | -17.2 | — | — | 1 | BEARISH | -12.5 |
| ALKS Alkermes plc | $6.8B | 103.6 | 3.9 | 2.9 | 0.1 | 10.8 | 4 | BEARISH | 36.2 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
AVDL vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F